Steven Fiering

12.8k total citations · 3 hit papers
159 papers, 10.2k citations indexed

About

Steven Fiering is a scholar working on Molecular Biology, Immunology and Genetics. According to data from OpenAlex, Steven Fiering has authored 159 papers receiving a total of 10.2k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Molecular Biology, 42 papers in Immunology and 30 papers in Genetics. Recurrent topics in Steven Fiering's work include Immunotherapy and Immune Responses (28 papers), Genomics and Chromatin Dynamics (20 papers) and Virus-based gene therapy research (19 papers). Steven Fiering is often cited by papers focused on Immunotherapy and Immune Responses (28 papers), Genomics and Chromatin Dynamics (20 papers) and Virus-based gene therapy research (19 papers). Steven Fiering collaborates with scholars based in United States, United Kingdom and Iran. Steven Fiering's co-authors include David I. K. Martin, Mark Groudine, Nicole F. Steinmetz, Emma Whitelaw, David Garrick, Garry P. Nolan, Seiko Toraya‐Brown, L A Herzenberg, Mee Rie Sheen and Jean‐François Nicolas and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Genetics.

In The Last Decade

Steven Fiering

153 papers receiving 10.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Repeat-induced gene silencing in mammals

1998 759 citations Steven Fiering et al. profile →
In situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancer

2015 391 citations Patrick H. Lizotte, Nicole F. Steinmetz et al. profile →
Cancer therapy with iron oxide nanoparticles: Agents of thermal and immune therapies

2020 295 citations Steven Fiering et al. profile →

Peers

Steven Fiering

IMMUN

GENET

ONCOL

Michael Bachmann Germany

Don J. Diamond United States

Nicolle H. Packer Australia

Robert Liddington United States

Arne Skerra Germany

David W. Speicher United States

Hubert Kalbacher Germany

Jianbin Wang China

Anna Huttenlocher United States

Sylviane Muller France

Michael Bachmann Germany

Steven Fiering

3.9k ×0.7

3.1k ×1.3

IMMUN

1.2k ×0.7

GENET

4.0k ×2.8

ONCOL

1.5k ×1.3

Citations per year, relative to Steven Fiering Steven Fiering (= 1×) peers Michael Bachmann

Countries citing papers authored by Steven Fiering

Since Specialization

Citations

This map shows the geographic impact of Steven Fiering's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Fiering with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Fiering more than expected).

Fields of papers citing papers by Steven Fiering

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven Fiering. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Fiering. The network helps show where Steven Fiering may publish in the future.

Co-authorship network of co-authors of Steven Fiering

This figure shows the co-authorship network connecting the top 25 collaborators of Steven Fiering. A scholar is included among the top collaborators of Steven Fiering based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven Fiering. Steven Fiering is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhao, Zhongchao, et al.. (2026). Bioprinting collagenase-responsive hydrogel for controlled release of cowpea mosaic virus immunotherapy. Biofabrication. 18(1). 15027–15027.

Fields, Jennifer, et al.. (2025). Intratumoral Immunotherapy with Cowpea Mosaic Virus and Interleukin-12 Eliminates Established Treated Tumors and Generates Robust Systemic Immunity to Suppress the Growth of Untreated Metastatic Tumors. Molecular Pharmaceutics. 22(7). 3747–3756.

Zhao, Zhongchao, Yi Xiang, Edward C. Koellhoffer, et al.. (2024). 3D bioprinting cowpea mosaic virus as an immunotherapy depot for ovarian cancer prevention in a preclinical mouse model. Materials Advances. 5(4). 1480–1486. 2 indexed citations

Xiang, Yi, et al.. (2024). Multifaceted cancer alleviation by cowpea mosaic virus in a bioprinted ovarian cancer peritoneal spheroid model. Biomaterials. 311. 122663–122663. 4 indexed citations

Koellhoffer, Edward C., Veronique Beiss, Lu Wang, et al.. (2022). Inactivated Cowpea Mosaic Virus in Combination with OX40 Agonist Primes Potent Antitumor Immunity in a Bilateral Melanoma Mouse Model. Molecular Pharmaceutics. 19(2). 592–601. 11 indexed citations

Guerrera, Diego, María Dolores Pérez Alenza, Stanislav Pantelyushin, et al.. (2022). Neoadjuvant in situ vaccination with cowpea mosaic virus as a novel therapy against canine inflammatory mammary cancer. Journal for ImmunoTherapy of Cancer. 10(3). e004044–e004044. 38 indexed citations

Beiss, Veronique, et al.. (2022). In situ vaccination with cowpea mosaic virus elicits systemic antitumor immunity and potentiates immune checkpoint blockade. Journal for ImmunoTherapy of Cancer. 10(12). e005834–e005834. 25 indexed citations

Beiss, Veronique, et al.. (2021). Cowpea mosaic virus stimulates antitumor immunity through recognition by multiple MYD88-dependent toll-like receptors. Biomaterials. 275. 120914–120914. 65 indexed citations

Shahgolzari, Mehdi, Hassan Dianat‐Moghadam, & Steven Fiering. (2021). Multifunctional plant virus nanoparticles in the next generation of cancer immunotherapies. Seminars in Cancer Biology. 86(Pt 2). 1076–1085. 21 indexed citations

10.

Shahgolzari, Mehdi, Maghsoud Pazhouhandeh, Morteza Milani, Ahmad Yari Khosroushahi, & Steven Fiering. (2020). Plant viral nanoparticles for packaging and in vivo delivery of bioactive cargos. Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology. 12(5). e1629–e1629. 28 indexed citations

11.

Shukla, Sourabh, Chao Wang, Veronique Beiss, et al.. (2020). The unique potency of Cowpea mosaic virus (CPMV) in situ cancer vaccine. Biomaterials Science. 8(19). 5489–5503. 58 indexed citations

12.

Fiering, Steven, et al.. (2019). Cecropin-like antimicrobial peptide protects mice from lethal E.coli infection. PLoS ONE. 14(7). e0220344–e0220344. 15 indexed citations

13.

Alexander, Matthew P., Steven Fiering, Gary R. Ostroff, Robert A. Cramer, & David W. Mullins. (2018). Beta-glucan-induced inflammatory monocytes mediate antitumor efficacy in the murine lung. Cancer Immunology Immunotherapy. 67(11). 1731–1742. 33 indexed citations

14.

Hoopes, P. Jack, Róbert Wágner, Kayla Duval, et al.. (2018). Treatment of Canine Oral Melanoma with Nanotechnology-Based Immunotherapy and Radiation. Molecular Pharmaceutics. 15(9). 3717–3722. 101 indexed citations

15.

Varn, Frederick S., Yue Wang, David W. Mullins, Steven Fiering, & Chao Cheng. (2017). Systematic Pan-Cancer Analysis Reveals Immune Cell Interactions in the Tumor Microenvironment. Cancer Research. 77(6). 1271–1282. 116 indexed citations

16.

Rahme, Gilbert J., Zhonghua Zhang, Alison L. Young, et al.. (2016). PDGF Engages an E2F-USP1 Signaling Pathway to Support ID2-Mediated Survival of Proneural Glioma Cells. Cancer Research. 76(10). 2964–2976. 30 indexed citations

17.

Baird, Jason R., Barbara A. Fox, Patrick H. Lizotte, et al.. (2013). Avirulent Toxoplasma gondii Generates Therapeutic Antitumor Immunity by Reversing Immunosuppression in the Ovarian Cancer Microenvironment. Cancer Research. 73(13). 3842–3851. 84 indexed citations

18.

Cubillos‐Ruiz, Juan R., Jason R. Baird, Amelia J. Tesone, et al.. (2012). Reprogramming Tumor-Associated Dendritic Cells In Vivo Using miRNA Mimetics Triggers Protective Immunity against Ovarian Cancer. Cancer Research. 72(7). 1683–1693. 124 indexed citations

19.

Scarlett, Uciane K., Melanie R. Rutkowski, Adam M. Rauwerdink, et al.. (2012). Ovarian cancer progression is controlled by phenotypic changes in dendritic cells. The Journal of Experimental Medicine. 209(3). 495–506. 243 indexed citations

20.

Liu, Xi, Lorenzo F. Sempere, Fabrizio Galimberti, et al.. (2009). Uncovering Growth-Suppressive MicroRNAs in Lung Cancer. Clinical Cancer Research. 15(4). 1177–1183. 151 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact